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Abstract

Methods

RNA purification and amplification:
RNA was isolated using the Direct-zol RNA Mini-Prep kit by following the instructions from the
manufacturer. For cDNA synthesis, the Taqman Reverse Transcription kit was used as
described by the manufacturer. Real time PCR was performed using Taqman gene
expression assays (Thermo Fisher) and Taqman Universal Master Mix reagents. The primers
used are for GAPDH and SAT1.
Proliferation assays:
MSCs were exposed to inhibitors at 10 μM for 6 days. A cell count was conducted using a
hemocytometer at days 0, 2, 4 and 6.
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Figure 2. mRNA expression of SAT 1
compared to GAPDH during osteogenesis
over time.
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Figure 6. MSCs exposed to inhibitors at 10 μM.
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four times, days 0, 2,4,and 6 (n = 8).
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*

Previous data shows
that supplementation of spermidine decreases
*
ALP, an osteogenic marker. Past results also show that SAT1
expression
is increased during osteogenesis. Furthermore,
*
inhibition by CDAP decreases ALP while an inhibition by DFMO
* increases ALP. These results together support the hypothesis that
depletion of polyamine levels is necessary for osteogenesis.
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Figure 1. Polyamine pathway with
inhibitors shown in red.
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Results

Cell number (x10 4)

To explore how polyamines effect osteogenic differentiation we
inhibited and silenced key enzymes in the biochemical pathway.
Silencing was achieved as previously described by Ramsey et
al, with shSMS. Inhibition was with cyclohexyl-1,3diaminopropane (CDAP) and difluoromethylornithine (DFMO.
CDAP inhibits SMS. DFMO inhibits Ornithine Decarboxylase
(ODC) which produces putrescene, the main polyamine butyl
moiety. Inhibition at this level halts the polyamine pathway,
reducing spermidine and spermine levels.
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SRS is a rare disorder that is caused by an X-linked mutation
which has a dysfunctional Sms gene (Ramsay 2019). Sms
encodes for Spermine Synthase (SMS), an aminopropyl
transferase that catalyzes the conversion of spermidine into
spermine (Lee 2010). There seems to be variation in severity of
the disorder. This may be due to SMS being more functional in
different individuals. An observed consequence of this disorder is
an imbalance in spermidine and spermine ratio (Shwartz 1993).
As less spermine is produced, spermidine becomes more
abundant. The pathological mechanism of this imbalance is still
not well known.

Osteoblast activity assays:
At day 14, osteoblast activity was quantified by measuring alkaline phosphatase (ALP) levels.
In brief, cells were detached with Trypsin, centrifuged at 15000 × g , then placed in ALP buffer
and vortexed. Afterward the cells were placed in a shaker on ice for 20 minutes, centrifuged
again, and the supernatant collected. ALP activity was measured by reading the optic density
of the solution with pNPP using a plate reader at 405 nm. Protein concentration was
quantified using Coomassie stain and read at 595 nm. Osteoblast activity is measured by the
ALP / protein ratio.
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Osteogenic differentiation in vitro:
MSCs were placed into 12-well plates with a concentration of 50,000 cells/well. The next day,
medium was changed to osteogenic media (MEM-α + 10% FBS with 0.2 mM ascorbic acid,
0.1 μM dexamethasone, and 10 mM β-glycerolphosphate) with medium changes every 3–4
days.

ALP (rel to Protein conc.)

Snyder-Robinson Syndrome (SRS) is a rare disorder that is
characterized by skeletal defects due to severe osteoporosis.
SRS is caused by a mutation in the gene coding for Spermine
Synthase (SMS). SMS converts spermidine into spermine via
an electrophilic addition. Much still needs to be elucidated about
polyamines, especially their roles in osteogenesis. In this study
specifically spermidine, promotes osteogenesis. During osteo
differentiation it is shown that Spermidine/Spermine
Acetyltransferase (SSAT1) is upregulated, further suggesting
polyamine depletion is necessary for osteogenesis. This data
indicates that a reduction of polyamines is necessary for osteo
differentiation.
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